Tritium to supply DC charging stations to Elexent by Renault
Australian charging equipment supplier Tritium teams up with Renault’s dedicated charging division Elexent. The supply agreement commits Tritium to deliver fast-charging stations for installation in more than ten European countries.
Neither Elexent nor Tritium disclosed how many chargers the deal entails. They will use the Tritium RT50 and RTM75. A relatively compact design characterises both models, and the charging power is the eponymous DC 50 and 75 kW, respectively.
Renault had established Elexent in July 2020 to help other companies find solutions for charging their electric or plug-in hybrid vehicle fleets through the service provider. Elexent launched in France but planned to become active across Europe, as evidenced by its plan for fast chargers in ten countries.
“To adequately address the growing need for fleet charging, it was necessary to find partners as trusted as Tritium,” said Nicolas Schottey, CEO of Elexent. He added the company was to offer customers “the most advanced and reliable DC fast chargers for electric vehicles.”
Tritium on Twitter added that fleet customers would gain access to advanced and reliable charging solutions, tailored to their needs, through the partnership.
Tritium recently upgraded its entire range of fast-chargers to Plug&Charge capability. As soon as the charging cable is plugged in and authenticates the vehicle, an encrypted certificate crosses the cloud for approval before activating the charge. The technology conforms with ISO 15118 to protect communication between the infrastructure and the car against manipulation.
Drivers of Plug& Charge-enabled vehicles such as the Porsche Taycan or the incoming E-GMP electric cars by Hyundai and Kia can, in future, just plug-in and start charging. In August 2020, Tritium also introduced the RT175-S, a new Plug&Charge-enabled fast-charging station with up to 175 kW.
Tritium has been in the market since 2001 and is also a high power charging partner to Ionity.
- ADVERTISEMENT -